Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...
Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...
HHS Assistant Secretary of Public Affairs Tom Corry unexpectedly stepped down on Feb. 28. In a brief post on X Monday morning ...
Bizcommunity.com on MSN14h
Oscars reach unprecedented demand with sold-out ads and A-list sponsorsDisney Advertising has announced that it sold out of advertising inventory for the 97th Oscars telecast. The event, hosted ...
Teva Pharmaceutical Industries Ltd. ADR-2.31% $19B ...
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.
Vaginitis Treatment Drug MarketThe global vaginitis treatment drug market is projected to grow from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, expanding at a CAGR of 4.8%. This growth ...
CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the fourth quarter and year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback